Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Researchers Define Precursors To Cells That Control The Immune Response

Date:
November 12, 2001
Source:
University Of Pittsburgh Medical Center
Summary:
University of Pittsburgh researchers have identified the precursors of epidermal Langerhans cells (LCs), cells that reside in the skin and play a key role in the initiation and regulation of the immune response throughout the body. Researchers may now be able to use these cells to manipulate and control the immune response, according to the groundbreaking study to be published in the December issue of Nature Immunology.

PITTSBURGH, Nov. 11 - University of Pittsburgh researchers have identified the precursors of epidermal Langerhans cells (LCs), cells that reside in the skin and play a key role in the initiation and regulation of the immune response throughout the body. Researchers may now be able to use these cells to manipulate and control the immune response, according to the groundbreaking study to be published in the December issue of Nature Immunology, and as an advanced online publication on the journal's Web site on Monday, Nov. 12.

Related Articles


Through genetic engineering, the cells could be targeted for the delivery of genes encoding for specific antigens and immunoregulatory molecules, signaling either the start or stop of the immune response, say the University of Pittsburgh researchers. The team also hopes to be able to use these precursors, through tissue engineering, to repopulate artificial skin with an intact immune system.

"By manipulating the function of Langerhans cells, we may be able to initiate an immune response, which could enhance vaccine development. We may also have the potential to down-regulate or turn off an immune response, creating novel treatments for asthma or other auto-immune diseases and anti-rejection therapies in transplantation," said Louis D. Falo, Jr., M.D., Ph.D., senior investigator for the study and professor and chairman, department of dermatology, University of Pittsburgh School of Medicine.

LCs are a subset of dendritic cells (DCs) present in the epidermis of the skin that show an extraordinary immunostimulatory capacity. They are antigen-presenting cells, meaning that when the LCs encounter an antigen in the presence of a "danger signal" like a pathogen or infection, they migrate from the skin to the lymph nodes, presenting a processed antigen to T-cells, initiating antigen-specific T-cell immunity.

"Scientists have known that LC precursors existed; however, the identification of an immediate LC precursor resident in the skin remained as a missing link," said Adriana T. Larregina, M.D., Ph.D., research assistant professor, department of dermatology, University of Pittsburgh School of Medicine, who led the study with Adrian E. Morelli, M.D., Ph.D., research assistant professor, department of surgery, University of Pittsburgh School of Medicine and Thomas E. Starzl Transplantation Institute. "By defining them, we gain the ability to target or retrieve the cells and study their therapeutic potential."

To identify the precursors, University of Pittsburgh researchers targeted a population of migratory cells present in the dermis of human skin, which expressed molecules that distinguish LCs from other types of DCs. They found that when these cells were cultured with transforming growth factor-beta 1, a growth factor that plays a role in differentiation and the immune response, the cells differentiated into epidermal LCs. When cultured in granulocyte macrophage-colony-stimulating factor, a protein that promotes the recovery of white cells, and interleukin-4, proteins present in inflamed skin, the precursors acquired a strong immune stimulatory function, differentiating into functionally mature DCs. By defining these precursor cells, researchers now can begin to investigate their therapeutic potential.

University of Pittsburgh researchers participating in this study, in addition to Dr. Falo, Dr. Larregina and Dr. Morelli, include: Lori A. Spencer, M.D., Ph.D., immunology program, School of Medicine; Alison Logar, Starzl Transplantation Institute; Angus W. Thomson, Ph.D., D.Sc., Starzl Transplantation Institute; and Simon C. Watkins, Ph.D., department of physiology, School of Medicine.

The study was funded by grants from the National Institutes of Health and from the Dermatology Foundation.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Define Precursors To Cells That Control The Immune Response." ScienceDaily. ScienceDaily, 12 November 2001. <www.sciencedaily.com/releases/2001/11/011112073456.htm>.
University Of Pittsburgh Medical Center. (2001, November 12). University Of Pittsburgh Researchers Define Precursors To Cells That Control The Immune Response. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2001/11/011112073456.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Define Precursors To Cells That Control The Immune Response." ScienceDaily. www.sciencedaily.com/releases/2001/11/011112073456.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins